Advertisement

Insulin Like Growth Factor II mRNA-Binding Protein 3 (IMP3) Immunohistochemical Expression in Salivary Glands Tumors- Local Study

Research Article | DOI: https://doi.org/10.31579/2834-8508/031

Insulin Like Growth Factor II mRNA-Binding Protein 3 (IMP3) Immunohistochemical Expression in Salivary Glands Tumors- Local Study

  • Rand M. Anwer 1*
  • Faaiz Alhamdani 2
  • Saba A. Abdulkareem 3

1Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad

2Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad

3Ghazy Al-Hariri Hospital for Surgical Specialties/Medical City, Baghdad, Iraq

*Corresponding Author: Rand M. Anwer, Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad.

Citation: Rand M. Anwer, Faaiz Alhamdani, Saba A. Abdulkareem (2024), Insulin Like Growth Factor II mRNA-Binding Protein 3 (IMP3) Immunohistochemical Expression in Salivary Glands Tumors- Local Study. Archives of Clinical and Experimental Pathology. 3(4); Doi:10.31579/2834-8508/031

Copyright: © 2024 Rand M. Anwer, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 13 June 2024 | Accepted: 01 July 2024 | Published: 15 July 2024

Keywords: insulin like growth factor ii, imp3, benign, malignant, pleomorphic adenoma.

Abstract

Objective: To identify the relationship between the expression of IMP3 in benign and malignant tumors of salivary glands and other clinic-pathological variables.

Materials and Methods: Twenty-six cases of salivary gland tumors were collected from the histopathology department, Gazi-Hariri hospital/ Baghdad Medical City from January 2021 to June 2021. Patients’ reports were included for diagnosis and clinicopathological data. Three histological sections were taken from the paraffin blocks for each case. The first section was stained with H&E stain, and the other two sections were stained with IMP3 (Dako-code M3626) monoclonal antibody by the immunohistochemical method.

Results: Twenty-six cases of salivary gland tumor, with equal male/female distribution; the mean age for the patients was 45 years (19-60 years). There was no significant relationship between gender (P=.0.115), tumor size (P=0.359), tumor location (P=0.335), and tumor type (P=0.673) with positive expression of IMP3. Regarding malignant cases, no significant relation between IMP3 expression and tumor stage (P=1.000), and lymphovascular invasion (P=1.000). On the other hand, there was a highly significant relationship (P=0.000) between IMP3 expression and cell type (epithelial/mesenchymal). 

Conclusion: Imp3 might not be conclusive in differentiation between benign and malignant salivary gland tumors. Further studies with follow-up are needed to assess the prognostic value of this marker in salivary gland pathologies.

Introduction

Salivary gland tumors are uncommon tumors. They account for 3% of the total body tumors and 2% to 6.5% of all neoplasms of the head and neck. Salivary glands tumors are rare in general [1], in Iraq, it represents 0.37% of all cancers in 2020 [2, 3]

They show a wide variety of presentations and behaviours with 24 types and subtypes of both benign and malignant salivary glands [1, 4-8]. Tumor variation appears in the cell of origin (epithelial, acinar, ductal, myoepithelial cells, and stromal elements [1, 4-8].

The behaviour of salivary gland tumors, malignant tumors in particular is a matter of debate. It seems that the microscopic grade of salivary gland carcinoma is an independent predictor oftumour behavior [2]. The current knowledge of the genetic changes in salivary gland carcinomas opens the doors widely for the study of different biomarkers for their diagnostic and prognostic values [9, 10].

One of these markers is Insulin-like growth factor-II mRNA-binding protein-3 (IMP3). It has been considered as a prognostic factor in some cancers and a tool that differentiates between benign and malignant pancreatic lesions.”2, 3”: However, its value in salivary gland tumors is yet to be confirmed.

This case series study aimed to identify the relationship between the expression of IMP3 in benign and malignant tumors of salivary glands and other clinic-pathological variables.

Materials and Method

Twenty-six cases of salivary gland tumors were collected from the histopathology department, Gazi-Hariri hospital/ Baghdad Medical City from January 2021 to June 2021.Patients’ reports were included for diagnosis and clinicopathological data.

Three histological sections were taken from the paraffin blocks for each case. The first section was stained with H&E stain, and the other two sections were stained with IMP3(Dako-code M3626) monoclonal antibody by the immuno- histochemical method.

Slides Dewaxing, antigen iniucei-heat retrieval with ph.9(Dako DM828) solution for 20 minutes in awater bath at 95 C⁰. Immune histochemical staining protocol using HRPT/ chromogranin detection kit (Dako K8023) was followed as in the reference method [11].

Both H&E and immuno-histochemical stained slides were examined independently by two pathologists positive and negative control was included.

The expression of IMP3 sasrecorded as positive shen brown signal is found within the cytoplasm /nucleus of tumor cells, theintensity of the signal was scored as 1+ when faint focal cytoplasmic stain, (2+) when intense diffuse cytoplasmic/ nuclear stain, and 3+ for very deep brown diffuse stain, and the percentage of cells also included [7].

Both descriptive and inferential statistics were performed using SPSS Ver.25. Chi-Square Test was used to determine the association between the variables. P<0>

Results

Twenty-sixcases of salivary gland tumor, with equal male/female distribution; the mean age for the patients was 45 years (19-60 years). Table 1 shows the distribution of tumors among cases.

No. of casesType of tumorAffected gland
12Pleomorphic adenomaParotid gland
6Warthin’s tumorParotid gland
3Muco-epidermoid carcinomaParotid gland,tong
3Low-grade AdenocarcinomaThe floor of the mouth,hard palate, softpalate
1Cyto-adenocarcinomaParotid gland
1Malignant pleomorphic adenomaSubmandibular gland

Table 1: The distribution of the tumors in the cases

Chi-Square Tests

 Value

Df

Asymptotic

Significance (2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)

Point

Probability

Pearson Chi-Square.722a

1

.395.673.336 
Continuity Correctionb.181

1

.671   
Likelihood Ratio.728

1

.394.673.336 
Fisher's ExactTest   .673.336 

Linear-by-Linear

Association

.694c

1

.405.673.336.236
N of Valid Cases26     
No significant relationship between tumortype and IMP3 expression

Table 2: Relationship between tumor type and IMP3 expression

Chi-Square Tests

 Valuedf

Asymptotic Significance

(2-sided)

Exact Sig. (2-

sided)

Exact Sig. (1-

sided)

Point

Probability

Pearson Chi-Square26.000a2.000.000  
Likelihood Ratio36.0442.000.000  
Fisher's ExactTest28.521  .000  

Linear-by-Linear

Association

20.014b1.000.000.000.000
N of Valid Cases26     
a.     4 cells(66.7%) have expected count less than 5. Theminimum expected countis 2.00. Highly significant relationship the tissue involved and IMP3 expression

Table 3: Relationship the tissue involved and IMP3 expression

Both epithelial and mesenchymal cells were evaluated normal salivary tissue shows anegative stain. The presence of brown stain (cytoplasmic and/or nuclear) within the tumor cells isregarded as positive (Figure 1-1). Thestaining intensity on a scale of (1+,2+, and 3+).

Regarding the benign cases, four cases of Warthin tumor show weak 1+ focal signal in few cells. All the cases of pleomorphic adenoma showed apositive 2+ signal within the chondromyxoid areas (Figure 1-2) while the epithelial part show only aweak few scattered positive cells in two cases.

During the scoring process, some cases showed just afew scattered positive cells, which was confusing, only positive groups of cells (more than 5) were considered positive. All three cases of mucoepidermoid carcinoma showed positive 1+ focal (5-10%) stains of the tumor cells (Figure 3&4), while the other types of malignant tumors were negative.

There was no significant relationship between gender (P=.0.115), tumor size (P=0.359), tumor location (P=0.335), and tumor type (P=0.673) with positive expression of IMP3. Regarding malignant cases, no significant relation between IMP3 expression and tumor stage (P=1.000), and lymphovascular invasion (P=1.000).

There was ahighly significant relationship (P=0.000) between IMP3 expression and cell type (epithelial/mesenchymal).

Figure 1: 1)- Medium power view showing positive cytoplasmic 2+ stain of IMP3 in Mucoepidermoied carcinoma; 2)- Medium power view of weak postive1+ Imp3, in pleomorphic adenoma; 3&4)- Medium power view, focal positivity 1-2+ of IMP3 in mucoepidermoied carcinoma

Discussion

IMP3 is a binding-RNA protein required for ribosomal RNA processing, which has been suggested to be a prognostic marker in a large variety of cancers in humans. However, available data on the prevalence of IMP3 expression is largely debatable. IMP3 was frequently expressed in many different tumor types and was typically associated with aggressive tumor features [4, 7].

The pathogenesis and molecular changes in salivary gland tumors arestill under study. In this case series study, the immunohistochemical expression of the fetal oncogene IMP3 has been investigated for its relation to tumor classical clinicopathological criteria.

The neoplastic cells exhibit differentiation of epithelial cells (luminal), myoepithelial cells و as well as a very characteristic stromal tissue comprising chondroid, myxoid, osseous and myxo-chondroidelements [8], which were evaluated also as part of Imp3 assessment.

In this study, most the cases were benign pleomorphic adenomas which is the most common tumor type [1, 3, 8,12] it is histologically characterized by the complex intermingling of mesenchymal-epithelial areas. There was an

interesting finding, which was the positive stain within the chondroid areas in pleomorphic adenoma. This finding can be explained by the presence ofthe cells. Despite they are normal cells, they show positive stain for IMP3”8”.

The absence of significant association between IMP3 expression with 'patients age, gender, and anatomical location, in benign variants, agrees with Mohamed R et al., However, this study's findings do not agree with Mohamed R et al., [4] and Burdelski C et al., studies [7] in the insignificant association between mucoepidermoid carcinoma and IMP3 expression may due to the low case number, especially the malignant ones.

One important limitation of this study was the low number of cases was a major restriction in the evaluation of the IMP3. The low number of collected cases might be related to data collection, which was affected by the COVID19 epidemic where theoral pathology department was closed.

The significant association between IMP3 expression and epithelial/mesenchymal cells similar to Christoph Burdelski et al., [7] may bedue to the variation in expression between normal tissue and tumor since most ofthe cases were benign pleomorphic adenoma like Faris k.”12” and Omar ShebliMuseedi et al., [2] and this tumor contains mixed tissue, while other tumor types especially carcinomas are predominantly epithelial.

Conclusion

There is variation in IMP3 expression between normal, benign, and malignant tissue. IMP3 might not be conclusive in differentiation between benign and malignant salivary gland tumors. Further studies with follow-up are needed to assess the prognostic value of this marker in salivary gland pathologies.

References

Clinical Trials and Clinical Research: I am delighted to provide a testimonial for the peer review process, support from the editorial office, and the exceptional quality of the journal for my article entitled “Effect of Traditional Moxibustion in Assisting the Rehabilitation of Stroke Patients.” The peer review process for my article was rigorous and thorough, ensuring that only high-quality research is published in the journal. The reviewers provided valuable feedback and constructive criticism that greatly improved the clarity and scientific rigor of my study. Their expertise and attention to detail helped me refine my research methodology and strengthen the overall impact of my findings. I would also like to express my gratitude for the exceptional support I received from the editorial office throughout the publication process. The editorial team was prompt, professional, and highly responsive to all my queries and concerns. Their guidance and assistance were instrumental in navigating the submission and revision process, making it a seamless and efficient experience. Furthermore, I am impressed by the outstanding quality of the journal itself. The journal’s commitment to publishing cutting-edge research in the field of stroke rehabilitation is evident in the diverse range of articles it features. The journal consistently upholds rigorous scientific standards, ensuring that only the most impactful and innovative studies are published. This commitment to excellence has undoubtedly contributed to the journal’s reputation as a leading platform for stroke rehabilitation research. In conclusion, I am extremely satisfied with the peer review process, the support from the editorial office, and the overall quality of the journal for my article. I wholeheartedly recommend this journal to researchers and clinicians interested in stroke rehabilitation and related fields. The journal’s dedication to scientific rigor, coupled with the exceptional support provided by the editorial office, makes it an invaluable platform for disseminating research and advancing the field.

img

Dr Shiming Tang

Clinical Reviews and Case Reports, The comment form the peer-review were satisfactory. I will cements on the quality of the journal when I receive my hardback copy

img

Hameed khan